Taylor Brenton 4

What Happened
Taylor Brenton, EVP of Operations & R&D at Sight Sciences, was granted 100,464 restricted stock units (RSUs) on 2026-02-03 (transaction type: Award). The grant size was set at $650,000 and the number of RSUs equals $650,000 divided by the closing stock price on 2026-02-03 (implied price ≈ $6.47 per share). Each RSU is a contingent right to receive one share of common stock upon vesting.

Key Details

• Transaction date: February 3, 2026; Form 4 filed February 5, 2026 (appears timely).
• Grant: 100,464 RSUs; reported acquisition price $0.00 (award).
• Vesting: 16 equal quarterly installments beginning March 31, 2026 and ending December 31, 2029, contingent on continued service (Footnote F1).
• Reported beneficial ownership (per filing footnote F2): includes 26,606 shares of common stock and 244,070 shares issuable upon vesting of unvested RSUs.
• No sale or cash exercise occurred; this is a compensation grant rather than an open‑market purchase or sale.

Context
RSU grants are common executive compensation and do not represent an immediate cash purchase or sale—value is realized only if and when RSUs vest and shares are issued. While insider purchases can be a clearer signal of personal conviction, awards primarily reflect company compensation policies and retention incentives; they should be interpreted accordingly and not as standalone buy/sell advice.